Showing 10,141 - 10,160 results of 32,204 for search '(( a step decrease ) OR ( 50 ((((mean decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 1.04s Refine Results
  1. 10141

    Table_1_Is Proton Therapy a “Pro” for Breast Cancer? A Comparison of Proton vs. Non-proton Radiotherapy Using the National Cancer Database.DOCX by Mudit Chowdhary (6016496)

    Published 2019
    “…On multivariate logistic analysis, the following factors were found to be significant for receipt of PRT (all p < 0.05): academic facility (odds ratio [OR] = 2.50), South (OR = 2.01) and West location (OR = 12.43), left-sided (OR = 1.21), ER-positive (OR = 1.59), and mastectomy (OR = 1.47); pT2-T4 disease predicted for decrease use (OR = 0.79). …”
  2. 10142

    Image_4_Is Proton Therapy a “Pro” for Breast Cancer? A Comparison of Proton vs. Non-proton Radiotherapy Using the National Cancer Database.pdf by Mudit Chowdhary (6016496)

    Published 2019
    “…On multivariate logistic analysis, the following factors were found to be significant for receipt of PRT (all p < 0.05): academic facility (odds ratio [OR] = 2.50), South (OR = 2.01) and West location (OR = 12.43), left-sided (OR = 1.21), ER-positive (OR = 1.59), and mastectomy (OR = 1.47); pT2-T4 disease predicted for decrease use (OR = 0.79). …”
  3. 10143

    Image_3_Is Proton Therapy a “Pro” for Breast Cancer? A Comparison of Proton vs. Non-proton Radiotherapy Using the National Cancer Database.pdf by Mudit Chowdhary (6016496)

    Published 2019
    “…On multivariate logistic analysis, the following factors were found to be significant for receipt of PRT (all p < 0.05): academic facility (odds ratio [OR] = 2.50), South (OR = 2.01) and West location (OR = 12.43), left-sided (OR = 1.21), ER-positive (OR = 1.59), and mastectomy (OR = 1.47); pT2-T4 disease predicted for decrease use (OR = 0.79). …”
  4. 10144

    Image_2_Is Proton Therapy a “Pro” for Breast Cancer? A Comparison of Proton vs. Non-proton Radiotherapy Using the National Cancer Database.pdf by Mudit Chowdhary (6016496)

    Published 2019
    “…On multivariate logistic analysis, the following factors were found to be significant for receipt of PRT (all p < 0.05): academic facility (odds ratio [OR] = 2.50), South (OR = 2.01) and West location (OR = 12.43), left-sided (OR = 1.21), ER-positive (OR = 1.59), and mastectomy (OR = 1.47); pT2-T4 disease predicted for decrease use (OR = 0.79). …”
  5. 10145

    Image_1_Is Proton Therapy a “Pro” for Breast Cancer? A Comparison of Proton vs. Non-proton Radiotherapy Using the National Cancer Database.pdf by Mudit Chowdhary (6016496)

    Published 2019
    “…On multivariate logistic analysis, the following factors were found to be significant for receipt of PRT (all p < 0.05): academic facility (odds ratio [OR] = 2.50), South (OR = 2.01) and West location (OR = 12.43), left-sided (OR = 1.21), ER-positive (OR = 1.59), and mastectomy (OR = 1.47); pT2-T4 disease predicted for decrease use (OR = 0.79). …”
  6. 10146

    Cryosections (8 µm) of intercostal muscle from a normal dog, a Labrador Retriever with CMS (end-plate AChE deficiency), and a Jack Russell Terrier with CMS due to AChR deficiency (... by Caitlin J. Rinz (622800)

    Published 2014
    “…In the CMS Jack Russell Terrier esterase staining was present; however, staining for AChR was markedly decreased or absent, consistent with a markedly decreased AChR content. …”
  7. 10147
  8. 10148
  9. 10149

    The SET Complex Acts as a Barrier to Autointegration of HIV-1 by Nan Yan (266514)

    Published 2009
    “…Here we show that knocking down any of the components of the SET complex, an endoplasmic reticulum-associated complex that contains 3 DNases (the base excision repair endonuclease APE1, 5′-3′ exonuclease TREX1, and endonuclease NM23-H1), inhibits HIV-1 and HIV-2/SIV, but not MLV or ASV, infection. Inhibition occurs at a step in the viral life cycle after reverse transcription but before chromosomal integration. …”
  10. 10150

    Reduction of cell viability via FINs is (partially) reversed by deferoxamine mesylate and ferrostatin-1. by Dino Bekric (16475280)

    Published 2024
    “…(A) Cell viability data is shown as mean values +/- SEM of n = 3 biological replicates of CCC-5 cells with FINs (light grey) and FINS + cell death inhibitors (dark grey) treatment for 24 h. …”
  11. 10151
  12. 10152
  13. 10153

    Insights into the Fragmentation of Aluminum Hydride and Its Effect on Combustion and Agglomeration of HTPB Propellant by Zhoufeng Jiang (1736425)

    Published 2024
    “…Compared to raw particles, the CCPs (condensed combustion products) of SP2 propellant display a 48% reduction in average size (<i>D</i><sub>50</sub> = 24.5 μm), whereas there is an over 89% decrease in particle size for the CCPs of SP3 propellant (<i>D</i><sub>50</sub> = 5.14 μm). …”
  14. 10154

    Insights into the Fragmentation of Aluminum Hydride and Its Effect on Combustion and Agglomeration of HTPB Propellant by Zhoufeng Jiang (1736425)

    Published 2024
    “…Compared to raw particles, the CCPs (condensed combustion products) of SP2 propellant display a 48% reduction in average size (<i>D</i><sub>50</sub> = 24.5 μm), whereas there is an over 89% decrease in particle size for the CCPs of SP3 propellant (<i>D</i><sub>50</sub> = 5.14 μm). …”
  15. 10155

    Insights into the Fragmentation of Aluminum Hydride and Its Effect on Combustion and Agglomeration of HTPB Propellant by Zhoufeng Jiang (1736425)

    Published 2024
    “…Compared to raw particles, the CCPs (condensed combustion products) of SP2 propellant display a 48% reduction in average size (<i>D</i><sub>50</sub> = 24.5 μm), whereas there is an over 89% decrease in particle size for the CCPs of SP3 propellant (<i>D</i><sub>50</sub> = 5.14 μm). …”
  16. 10156

    Insights into the Fragmentation of Aluminum Hydride and Its Effect on Combustion and Agglomeration of HTPB Propellant by Zhoufeng Jiang (1736425)

    Published 2024
    “…Compared to raw particles, the CCPs (condensed combustion products) of SP2 propellant display a 48% reduction in average size (<i>D</i><sub>50</sub> = 24.5 μm), whereas there is an over 89% decrease in particle size for the CCPs of SP3 propellant (<i>D</i><sub>50</sub> = 5.14 μm). …”
  17. 10157

    Insights into the Fragmentation of Aluminum Hydride and Its Effect on Combustion and Agglomeration of HTPB Propellant by Zhoufeng Jiang (1736425)

    Published 2024
    “…Compared to raw particles, the CCPs (condensed combustion products) of SP2 propellant display a 48% reduction in average size (<i>D</i><sub>50</sub> = 24.5 μm), whereas there is an over 89% decrease in particle size for the CCPs of SP3 propellant (<i>D</i><sub>50</sub> = 5.14 μm). …”
  18. 10158

    Demographic data. by Narisa Rattanalert (21445983)

    Published 2025
    “…Rubric scores for performing the LIO-ROP on a schematic eye significantly improved across all steps of the procedure between pre- and post-LIO-ROP practice. …”
  19. 10159
  20. 10160

    Sequence-Dependent T:G Base Pair Opening in DNA Double Helix Bound by Cren7, a Chromatin Protein Conserved among Crenarchaea by Lei Tian (369281)

    Published 2016
    “…Surface plasmon resonance assays revealed a 4-fold lower binding affinity of Cren7 for G<b>T</b>AATT<b>G</b>C than that for G<b>T</b>GATC<b>G</b>C, which was dominantly contributed by the decrease of association rate. …”